[{"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 4886, "interaction_type": "target", "pubmed_ids": "11752352|12590540|17643344|12784346|12227806|15121485", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 4887, "interaction_type": "enzyme", "pubmed_ids": "15304427|12891225|15025555", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 4888, "interaction_type": "enzyme", "pubmed_ids": "15304427|26053558", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P33261", "protein_name": "Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C19", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 4889, "interaction_type": "enzyme", "pubmed_ids": "15025555|15485308|15304427", "drugbank_id": "DB00673", "drug_name": "Aprepitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 14923, "interaction_type": "target", "pubmed_ids": "21149541", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 14924, "interaction_type": "target", "pubmed_ids": "21229983", "drugbank_id": "DB06634", "drug_name": "Casopitant", "drugtype": "Small Molecule", "Drug_status": 2, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 19114, "interaction_type": "target", "pubmed_ids": "20071423", "drugbank_id": "DB11386", "drug_name": "Chlorobutanol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q12809", "protein_name": "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)", "Protein_Class": "Ion channel", "gene_name": "KCNH2", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 5469, "interaction_type": "target", "pubmed_ids": "11752352|8141114|7493546|14635083|14586600|1397053|9257083|9341357|9506240|15740177", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 5470, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 5471, "interaction_type": "enzyme", "pubmed_ids": "16192915|8723743|22427733", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 5472, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00757", "drug_name": "Dolasetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 3415, "interaction_type": "target", "pubmed_ids": "17139284|17016423|12686391|11204352|11752352", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P21554", "protein_name": "Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)", "Protein_Class": "GPCR", "gene_name": "CNR1", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 3416, "interaction_type": "target", "pubmed_ids": "17139494|19226257", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P34972", "protein_name": "Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)", "Protein_Class": "GPCR", "gene_name": "CNR2", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 3417, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 3418, "interaction_type": "enzyme", "pubmed_ids": "19515014|16112652|19005461", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 3419, "interaction_type": "enzyme", "pubmed_ids": "19515014", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P23219", "protein_name": "Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)", "Protein_Class": "Enzyme", "gene_name": "PTGS1", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 3420, "interaction_type": "transporter", "pubmed_ids": "19887017|30583596", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 3421, "interaction_type": "transporter", "pubmed_ids": "19887017", "drugbank_id": "DB00470", "drug_name": "Dronabinol", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 6238, "interaction_type": "target", "pubmed_ids": "10412832|10882387|11814868|11752352|15740177|12943486|17093363|17379085|16044252", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 6239, "interaction_type": "enzyme", "pubmed_ids": "12943486|16192915|16248838", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 6240, "interaction_type": "enzyme", "pubmed_ids": "16248838|27809336|30950278", "drugbank_id": "DB00889", "drug_name": "Granisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P04798", "protein_name": "Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A1", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 6346, "interaction_type": "target", "pubmed_ids": "10065930|10517265|11763467|11972287|12032025|11752352|19320280|8588861|20098535|17269994|11919526|9506240|15740177", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 6347, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q13639", "protein_name": "5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)", "Protein_Class": "GPCR", "gene_name": "HTR4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 6348, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P35372", "protein_name": "Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)", "Protein_Class": "GPCR", "gene_name": "OPRM1", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 6349, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08908", "protein_name": "5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)", "Protein_Class": "GPCR", "gene_name": "HTR1A", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 6350, "interaction_type": "target", "pubmed_ids": "2164935", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P28222", "protein_name": "5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)", "Protein_Class": "GPCR", "gene_name": "HTR1B", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 6351, "interaction_type": "enzyme", "pubmed_ids": "8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 6352, "interaction_type": "enzyme", "pubmed_ids": "16946512|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 6353, "interaction_type": "enzyme", "pubmed_ids": "16192915|8591723", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 6354, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20815", "protein_name": "Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)", "Protein_Class": "Enzyme", "gene_name": "CYP3A5", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 6355, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P24462", "protein_name": "Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)", "Protein_Class": "Enzyme", "gene_name": "CYP3A7", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 6356, "interaction_type": "enzyme", "pubmed_ids": "11996015", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11712", "protein_name": "Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2C9", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 6357, "interaction_type": "enzyme", "pubmed_ids": "8723743", "drugbank_id": "DB00904", "drug_name": "Ondansetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05181", "protein_name": "Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)", "Protein_Class": "Enzyme", "gene_name": "CYP2E1", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 2740, "interaction_type": "target", "pubmed_ids": "15232725|11752352|14640928|16163194|14635083|15102873|17106506|19852528|17026451|14504060|15139789|14760130|15378559", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 2741, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873|16192915", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 2742, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 2743, "interaction_type": "enzyme", "pubmed_ids": "15378559|15102873", "drugbank_id": "DB00377", "drug_name": "Palonosetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P05177", "protein_name": "Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)", "Protein_Class": "Enzyme", "gene_name": "CYP1A2", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 18541, "interaction_type": "target", "pubmed_ids": "22497992", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P25103", "protein_name": "Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)", "Protein_Class": "GPCR", "gene_name": "TACR1", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 18542, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P10635", "protein_name": "Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)", "Protein_Class": "Enzyme", "gene_name": "CYP2D6", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 18543, "interaction_type": "enzyme", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 18544, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "Q9UNQ0", "protein_name": "Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)", "Protein_Class": "Transporter", "gene_name": "ABCG2", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 18545, "interaction_type": "transporter", "pubmed_ids": "nan", "drugbank_id": "DB09291", "drug_name": "Rolapitant", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08183", "protein_name": "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)", "Protein_Class": "Transporter", "gene_name": "ABCB1", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 5382, "interaction_type": "target", "pubmed_ids": "14534362|20398692|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P11229", "protein_name": "Muscarinic acetylcholine receptor M1", "Protein_Class": "GPCR", "gene_name": "CHRM1", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 5383, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P20309", "protein_name": "Muscarinic acetylcholine receptor M3", "Protein_Class": "GPCR", "gene_name": "CHRM3", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 5384, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08173", "protein_name": "Muscarinic acetylcholine receptor M4", "Protein_Class": "GPCR", "gene_name": "CHRM4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 5385, "interaction_type": "target", "pubmed_ids": "18045203|16175141|30566832", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08912", "protein_name": "Muscarinic acetylcholine receptor M5", "Protein_Class": "GPCR", "gene_name": "CHRM5", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 5386, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P43681", "protein_name": "Neuronal acetylcholine receptor subunit alpha-4", "Protein_Class": "Ion channel", "gene_name": "CHRNA4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 5387, "interaction_type": "target", "pubmed_ids": "15733544", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P17787", "protein_name": "Neuronal acetylcholine receptor subunit beta-2", "Protein_Class": "Ion channel", "gene_name": "CHRNB2", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 5388, "interaction_type": "target", "pubmed_ids": "20230815", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P14410", "protein_name": "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]", "Protein_Class": "Enzyme", "gene_name": "SI", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 5389, "interaction_type": "enzyme", "pubmed_ids": "16175141|11097144", "drugbank_id": "DB00747", "drug_name": "Scopolamine", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P08684", "protein_name": "Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)", "Protein_Class": "Enzyme", "gene_name": "CYP3A4", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Bronchioloalveolar Adenocarcinoma", "Disease_class": "Neoplasms"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Embryonal Neoplasm", "Disease_class": "Neoplasms"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Gastroparesis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Glioblastoma", "Disease_class": "Neoplasms"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Heroin Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Leukemia, Myelocytic, Acute", "Disease_class": "Neoplasms"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Pruritus", "Disease_class": "Pathological Conditions"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Severe Acute Respiratory Syndrome", "Disease_class": "Infections"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Dyspepsia", "Disease_class": "Pathological Conditions"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Overactive Bladder", "Disease_class": "Pathological Conditions"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Postoperative Nausea", "Disease_class": "Pathological Conditions"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Sleep Initiation and Maintenance Disorders", "Disease_class": "Nervous System"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Vomiting", "Disease_class": "Pathological Conditions"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Fibromyalgia", "Disease_class": "Musculoskeletal"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Alcohol Consumption", "Disease_class": "Behavior Mechanisms"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Alcoholic Intoxication, Chronic", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Anemia, Sickle Cell", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Anorexia Nervosa", "Disease_class": "Mental Disorders"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Arthritis of Knee", "Disease_class": "Musculoskeletal"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Arthritis, Psoriatic", "Disease_class": "Skin and Connective Tissue"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Cannabis Abuse", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "4", "Disease_name": "Cannabis Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Chronic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Common Migraine", "Disease_class": "Nervous System"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Essential Tremor", "Disease_class": "Nervous System"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Gilles De La Tourette Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Migraine with Aura", "Disease_class": "Nervous System"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Post-Traumatic Stress Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Sleep Apnea Syndromes", "Disease_class": "Respiratory Tract"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Substance-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Torticollis", "Disease_class": "Pathological Conditions"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Trichotillomania", "Disease_class": "Mental Disorders"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Alcohol Use Disorder", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Amphetamine-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Brain Diseases", "Disease_class": "Nervous System"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Cholecystitis", "Disease_class": "Digestive System"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Fish-Eye Disease", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "4", "Disease_name": "Gastroenteritis", "Disease_class": "Digestive System"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Genital Neoplasms, Female", "Disease_class": "Neoplasms"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Hallucinations", "Disease_class": "Pathological Conditions"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Hiv Infections", "Disease_class": "Infections"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Hypotension", "Disease_class": "Cardiovascular"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Irritable Bowel Syndrome", "Disease_class": "Digestive System"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Lymphoma, Follicular", "Disease_class": "Neoplasms"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Lymphoma, Non-Hodgkin", "Disease_class": "Neoplasms"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Malignant Tumor of Cervix", "Disease_class": "Neoplasms"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Mental and Behavioral Disorders Due to Use of Cocaine, Unspecified Mental and Behavioral Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Mycobacterium Avium-Intracellulare Infection", "Disease_class": "Infections"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Neuropathic Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Nicotine Dependence", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Obsessive-Compulsive Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Opioid-Related Disorders", "Disease_class": "Chemically-Induced Disorders"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Pancreatic Carcinoma", "Disease_class": "Digestive System"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Schizophrenia", "Disease_class": "Mental Disorders"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Tonsillitis", "Disease_class": "Infections"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Brain Neoplasms", "Disease_class": "Neoplasms"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Dysplastic Nevus Syndrome", "Disease_class": "Congenital and Neonatal"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Glioma", "Disease_class": "Neoplasms"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Hypertropia", "Disease_class": "Eye Diseases"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Malignant Neoplasm of Breast", "Disease_class": "Neoplasms"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Malignant Neoplasm of Stomach", "Disease_class": "Digestive System"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Multiple Myeloma", "Disease_class": "Neoplasms"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Malignant Neoplasm of Connective and Other Soft Tissue, Site Unspecified", "Disease_class": "Neoplasms"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Abdominal Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Alzheimer's Disease", "Disease_class": "Nervous System"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Amyotrophic Lateral Sclerosis", "Disease_class": "Nutritional and Metabolic"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Bipolar Disorder", "Disease_class": "Mental Disorders"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Drooling", "Disease_class": "Stomatognathic"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Endogenous Depression", "Disease_class": "Mental Disorders"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "3", "Disease_name": "Infection", "Disease_class": "Infections"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Major Depression, Single Episode", "Disease_class": "Mental Disorders"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Phobia, Social", "Disease_class": "Mental Disorders"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Renal Colic", "Disease_class": "Pathological Conditions"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "1", "Disease_name": "Senile Paranoid Dementia", "Disease_class": "Nervous System"}, {"interaction_id": 19462, "interaction_type": "target", "pubmed_ids": "nan", "drugbank_id": "DB11699", "drug_name": "Tropisetron", "drugtype": "Small Molecule", "Drug_status": 3, "protein": "P46098", "protein_name": "5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)", "Protein_Class": "Ion channel", "gene_name": "HTR3A", "Phase": "2", "Disease_name": "Pain", "Disease_class": "Pathological Conditions"}]